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ple that is truly representative of the Danish population, Thi-
eden’s findings are likely to be more applicable to 21st-cen-
tury Denmark, a quite northern country (latitude 551) blessed
with far more generous vacations than those who worked in
not quite tropical Boston (latitude 421) in the 1980s.
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Vitamin D Induces the Antimicrobial Protein hCAP18
in Human Skin
To the Editor:
Cathelicidins are a class of mammalian antimicrobial pep-
tides expressed in leukocytes and at epithelial surfaces
(Zanetti, 2004). Human cathelicidin antimicrobial protein
hCAP18 is encoded by CAMP (Ensembl Gene ID ENS
G00000164047) on chromosomal location 3p21 and is the
sole cathelicidin protein in humans. Recent studies have
shown that cathelicidins, in addition to being antimicrobial,
are multifunctional proteins with receptor-mediated effects
on eukaryotic cells and activity in chemotaxis, angiogene-
sis, and wound healing (Zaiou et al, 2003; Zanetti, 2004). In
the skin, there is low constitutive expression of hCAP18 in
the basal layer of keratinocytes but rapid upregulation upon
inflammation and injury (Frohm Nilsson et al, 1999; Dors-
chner et al, 2001; Heilborn et al, 2003).
Molecular mechanisms controlling the expression of
CAMP are still poorly understood. We have investigated
whether its expression could be influenced by agents that
affect the proliferation and differentiation of skin keratin-
ocytes. Human neonatal epidermal keratinocytes (Cascade
Biologics, Portland, Oregon) were cultured in EpiLife serum-
free keratinocyte growth medium (Cascade Biologics) con-
taining growth supplements and a calcium concentration of
0.06 mM. At 60% confluency, the agents assayed were
added to the medium and cells were harvested after 24 h.
RNA was extracted and reverse transcribed by standard
methods, and the expression was quantified by Real-Time
RT-PCR on an ABI Prism 7700 (Applied Biosystems, Foster
City, California) using 5 ng of cDNA according to standard
protocols. Sequences were 50-GTCACCAGAGGATTGTGA-
CTTCAA-30 and 50-TTGAGGGTCACTGTCCCCATA-30 for
the primers, and 6-FAM–50-CCGCTTCACCAGCCCGTC-
CTT-30–BHQ1 for the fluorigenic probe.
An upregulation of CAMP of about one order of magni-
tude was achieved by treatment with 100 nM MC903/ca-
lcipotriol, a vitamin D analog applied for psoriasis treatment
(Kragballe, 1995). Calcium is known to regulate major func-
tions of the epidermis including terminal differentiation. Pre-
treatment of cells by 1.5 mM calcium for 48 h increased the
expression by about 1.5-fold, and was synergistic to the
effects of MC903 (Fig 1a). Based on these findings, we as-
sayed the effect of vitamin D and its metabolites (all from
Fluka, Buchs, Switzerland). Both biologically active forms
of vitamin D3, i.e., 1,25(OH)2D3 and 25(OH)D3, stimulated
CAMP expression at the same magnitude as MC903. The
corresponding vitamin D2 analogs were slightly less effi-
cient. All compounds were active down to levels of 10 nM
(shown for 1,25(OH)2D3). The precursor of vitamin D bio-
synthesis, 7-dehydrocholesterol (7-DHC), was ineffective.
Western blot analysis confirmed that the elevated transcrip-
tion was reflected on the protein level (Fig 1b).
An in silico analysis revealed two putative vitamin D re-
sponsive elements (VDRE) of the DR3 type, and one puta-
tive heterodimer site of the DR5 type, within 1 kb upstream
of the transcription start (Table I). This region was subcloned
Figure 1
Age pattern of ultraviolet-B exposure. SPF indicates sun protective
factor; SAR, sun affinity ratio; and d, dose affiliations
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into a luciferase construct (pGL2-Basic) (Promega, Madi-
son, Wisconsin) and its promoter activity assayed by tran-
sfection into the human keratinocyte line HaCaT (Boukamp
et al, 1988). Treatment of the HaCaT cells with 1,25(OH)2D3
resulted in a 3-fold stimulation of the luciferase activity. By
combining 50-deletions in the promoter, and 10-bp deletions
or point mutations, the crucial element was located in
VDRE1 at 494/480, the deletion or mutation of which re-
moved 90% of the stimulatory effect (Fig 1c). In all mutation
constructs, a small responsivity (15% of the vitamin D sti-
mulatory response) to 1,25(OH)2D3 remained, indicating that
minor effects outside VDRE1 contributed to the overall ef-
fect. While this manuscript was being finalized, Wang et al
(2004) reported the stimulation of antimicrobial peptide ex-
pression by 1,25(OH)2D3, the responsive element described
being identical with VDRE1.
To assay the stimulation of CAMP expression in vivo, we
applied MC903/calcipotriol to the skin of 4 healthy individ-
uals. Twenty-five micrograms calcipotriol in 0.5 g ointment
(Daivonex, LEO Pharma, Malmo¨, Sweden) was applied to a
test area of 2  2.5 cm localized on the lower abdomen.
Vaseline (ACO, Stockholm, Sweden) served as control.
Punch biopsies were obtained after 24 h and frozen in-
stantly. All participants gave their written informed consent.
The study was approved by the Regional Committee of
Ethics and was conducted according to the Declaration of
Helsinki Principles. RNA was extracted and CAMP expres-
sion determined with Real-Time RT-PCR as described
above. Although varying between probands, a clear tran-
Figure1
Stimulation of CAMP expression by vitamin D in human keratin-
ocytes. (a) Expression of CAMP RNA in primary keratinocytes as
quantified by Real-Time RT-PCR is shown relative to the untreated
control. Keratinocytes were grown and treated as described above, for
vitamin D analogs at 100 nM if not stated otherwise. The samples were
evaluated in triplicates, the SD indicated with bars, and normalized by
quantification of 18S-RNA (Assay on Demand, Applied Biosystems). (b)
Western blot analysis of hCAP18 expression after 24 h treatment with
100 nM 1,25(OH)2D3. Protein was extracted in SDS-containing sample
buffer, separated on a 15% Tris-Glycine gel and electroblotted onto
nitrocellulose according to standard protocols (Ausubel et al, 2003).
Filters were reversibly stained with a 3% Ponceau S (Sigma, Sigma-
Aldrich, St. Louis, Missouri) solution in 3% TCA before incubating with
affinity-purified anti-LL-37 antiserum (Heilborn et al, 2003) at a 1:1000
dilution. Signals from horseradish peroxidase-conjugated secondary
IgG (Santa Cruz Biotechnology, Santa Cruz, California) using enhanced
chemiluminiscence (Amersham Biosciences, Piscataway, New Jersey)
were captured with a CCD camera (LAS 1000, Fujifilm, Tokyo, Japan).
(c) Determination of the Vitamin D responsible regions in the CAMP
promoter. The fragments assayed are shown with their position relative
to transcription start site þ1, referring to Ensembl Gene ID ENS
G00000164047. The position of putative vitamin D responsive elements
(VDRE) is indicated as black triangles. White triangles indicate deleted
VDRE and mutations are indicated as text. Freshly trypsinized and
suspended HaCaT cells were mixed with 2 mg of plasmid DNA pre-
complexed with Fugene 6 (Roche, Indianapolis, Indiana) according to
the manufacturer’s description, and seeded in a six-well plate at 1/5
confluence. After 24 h, the cells were treated with 1,25(OH)2D3 dis-
solved in DMSO, or DMSO in control assays. After a further 24 h, the
cells were lysed and luciferase measured in assay systems according
to the manufacturer’s instructions (Promega). Luciferase activity for
each construct in HaCaT cells, unstimulated (white bars) or stimulated
with 1 mM 1,25(OH)2D3 (gray bars), is shown relative to the basic activity
of the full-length fragment. The basal activity of wild-type and muta-
genized fragments 495/þ155 is identical and thus shown for wild-
type only. The activities are normalized against b-galactosidase, ex-
pressed from 100 ng of cotransfected plasmid (pEF1/LacZ, Invitrogen,
Paisley, UK). The results represent the mean of three experiments.
Table I. Putative VDR binding sites within the hCAP18
promoter
Putative
VDRE Sequences
Coordinates of
binding sites
VDRE 1 (þ ) CTGCTTCCCG GGTTCA ATG
GGTTCA AGTGATTCTC
494/480
cca
VDRE 2 () TCTCAGGTGA TCCGCC
CACCT TGGCCT CCCAAAGTGC
344/328
VDRE 3 (þ ) ATCTCCGGTC AGGTCT
GGG AGGTTG TCAGAGATGA
104/90
Displayed are the putative binding sites including 10 bp of the flanking
sequences, þ / indicating the sequence orientation. The core binding
motifs are indicated in bold. Underlined sequences were deleted in the in
vitro mutagenesis studies, and the small letters show the sequences in-
troduced as point mutations.
VDRE, vitamin D responsive elements.
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scriptional upregulation in all cases up to two magnitudes
was observed (Fig 2a). For one of the probands, the ex-
pression was also assayed by Western blot analysis, which
confirmed the upregulation of hCAP18 on the protein level
with evidence of the cleaved peptide LL-37 (Fig 2b). Topical
treatment with 1,25(OH)2D3 also produced upregulation of
hCAP18 in skin in vivo (not shown).
Our results confirm the findings of Wang et al (2004) and
in addition delineate the effects exerted by different vitamin
D compounds. Most importantly, we here demonstrate the
upregulation of hCAP18 in human skin in vivo following a
single application of vitamin D compounds topically. These
findings reveal an intriguing mechanism to enhance skin
protection, linking the UVB-dependent photochemical vita-
min D with hCAP18, involved in wound repair and antimi-
crobial defense. Under normal conditions, skin is the major
source of vitamin D in humans and its production is
dependent on ultraviolet radiation. UVB acts on the precur-
sor 7-DHC and forms provitamin D3, which is thermally
transformed to vitamin D3. Further hydroxylation steps to
produce 1,25(OH)2D3 occur in the liver and kidney, but also
skin keratinocytes contain the enzymatic machinery to fully
hydroxylate vitamin D3 and produce their own 1,25(OH)2D3
(Bikle et al, 1986). If exposure to sunlight is limited, the body
depends upon dietary intake of vitamin D3 from animal
food and vitamin D2 from plants. Since all vitamin D met-
abolites including vitamin D2 displayed significant activity,
this suggests that vitamin D regulation of hCAP18 may be a
conserved mechanism and not restricted to the skin.
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Reporting Hardy–Weinberg Tests in Case–Control Studies:
Reasons for Caution but not for Panic Reactions
To the Editor:
In this journal, Gyo¨rffy et al (2004) recently criticized the
failure to report results from statistical tests of Hardy–Wein-
berg equilibrium (HWE) in some case–control studies, also
citing our paper (Richter-Hintz et al, 2003). The authors
claimed that information about results from testing HWE
should be obligatory because deviations of the genotype
Figure 2
The expression of CAMP is upregulated by calcipotriol in human
skin in vivo. (a) Real-Time RT-PCR expression analysis was performed
on cDNA from skin biopsies of four probands locally treated with ca-
lcipotriol as described above. The stimulation of CAMP expression af-
ter treatment is shown relative to the respective untreated sample,
which is set as 1 (not shown). The biopsy also analyzed by Western blot
analysis is marked with an asterisk. (b) Western blot analysis on protein
extracts of skin biopsies obtained as described above.
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